We have completed the Phase II goals and submitted 3 manuscripts. We are currently working on Phase III goals:
- Team 1: Sensitivity Analysis in Real-World Studies
- Team 2: Real-World Evidence for Rare Diseases
- Team 3: Digital Healthcare Technologies, Decentralized Clinical Trials, and Real-World Evidence